- Home
- ZTR vs TMCI Comparison
ZTR vs TMCI Comparison
Compare ZTR & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZTR
- TMCI
- Stock Information
- Founded
- ZTR 1988
- TMCI 2014
- Country
- ZTR Australia
- TMCI United States
- Employees
- ZTR N/A
- TMCI N/A
- Industry
- ZTR Investment Managers
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ZTR Finance
- TMCI Health Care
- Exchange
- ZTR Nasdaq
- TMCI Nasdaq
- Market Cap
- ZTR 350.0M
- TMCI 401.8M
- IPO Year
- ZTR N/A
- TMCI 2021
- Fundamental
- Price
- ZTR $6.50
- TMCI $6.55
- Analyst Decision
- ZTR
- TMCI Hold
- Analyst Count
- ZTR 0
- TMCI 5
- Target Price
- ZTR N/A
- TMCI $8.40
- AVG Volume (30 Days)
- ZTR 219.4K
- TMCI 239.5K
- Earning Date
- ZTR 01-01-0001
- TMCI 11-06-2025
- Dividend Yield
- ZTR 12.09%
- TMCI N/A
- EPS Growth
- ZTR N/A
- TMCI N/A
- EPS
- ZTR N/A
- TMCI N/A
- Revenue
- ZTR N/A
- TMCI $213,751,000.00
- Revenue This Year
- ZTR N/A
- TMCI $10.63
- Revenue Next Year
- ZTR N/A
- TMCI $9.43
- P/E Ratio
- ZTR N/A
- TMCI N/A
- Revenue Growth
- ZTR N/A
- TMCI 7.67
- 52 Week Low
- ZTR $4.50
- TMCI $4.54
- 52 Week High
- ZTR $6.60
- TMCI $10.79
- Technical
- Relative Strength Index (RSI)
- ZTR 50.38
- TMCI 48.18
- Support Level
- ZTR $6.49
- TMCI $6.65
- Resistance Level
- ZTR $6.61
- TMCI $6.92
- Average True Range (ATR)
- ZTR 0.07
- TMCI 0.32
- MACD
- ZTR -0.02
- TMCI 0.05
- Stochastic Oscillator
- ZTR 26.32
- TMCI 59.23
About ZTR Virtus Total Return Fund Inc.
Virtus Total Return Fund Inc is a closed-end, diversified management investment company. Its investment objective of capital appreciation, with current income as a secondary objective. The Fund seeks to meet its objectives through a balance of equity and fixed income investments.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.